Rebeca Ocampo
YOU?
Author Swipe
View article: SARS-CoV-2 antibody and neutralization dynamics among persons with natural- and vaccine-induced exposures
SARS-CoV-2 antibody and neutralization dynamics among persons with natural- and vaccine-induced exposures Open
Previous SARS-CoV-2 research indicates that antibody levels and corresponding neutralization potential increase with additional exposures (comprising vaccination or infection), and that hybrid immunity resulting from combined vaccination a…
View article: Design and initial findings of a natural history study of anal HPV and associated lesions among young adult women in Costa Rica
Design and initial findings of a natural history study of anal HPV and associated lesions among young adult women in Costa Rica Open
Anal cancer is caused by HPV, and its incidence has increased globally over the last five decades. We conducted an anal HPV natural history study nested in the Costa Rica HPV Vaccine Trial (CVT) to quantitatively describe the natural histo…
View article: Descriptive epidemiology of gastric cancer in Costa Rica from 1990 to 2022 and projection of deaths to 2050: a population-based study
Descriptive epidemiology of gastric cancer in Costa Rica from 1990 to 2022 and projection of deaths to 2050: a population-based study Open
The study was supported by the Agencia Costarricense de Investigaciones Biomédicas-Fundación INCIENSA.
View article: Human papillomavirus (HPV) type 16 and type 18 antibody concentrations after a single dose of bivalent HPV vaccine in girls aged 9–14 years compared with three doses of quadrivalent HPV vaccine in women aged 18–25 years in Costa Rica (PRIMAVERA): a non-randomised, open-label, immunobridging, non-inferiority trial
Human papillomavirus (HPV) type 16 and type 18 antibody concentrations after a single dose of bivalent HPV vaccine in girls aged 9–14 years compared with three doses of quadrivalent HPV vaccine in women aged 18–25 years in Costa Rica (PRIMAVERA): a non-randomised, open-label, immunobridging, non-inferiority trial Open
For the Spanish translation of the abstract see Supplementary Materials section.
View article: Time course and determinants of the antibody response to SARS-CoV-2 in Costa Rica: the RESPIRA study
Time course and determinants of the antibody response to SARS-CoV-2 in Costa Rica: the RESPIRA study Open
RESPIRA Study ClinicalTrials.gov ID: NCT04537338 (3 September 2020).
View article: HPV16/18 antibodies 16-years after single dose of bivalent HPV vaccination: Costa Rica HPV vaccine trial
HPV16/18 antibodies 16-years after single dose of bivalent HPV vaccination: Costa Rica HPV vaccine trial Open
Background The Costa Rica HPV Vaccine Trial provided initial evidence that 1 dose of the bivalent human papillomavirus (HPV) vaccine induces stabilizing antibody levels that may provide extended protection against HPV-16/18 infections. We …
View article: Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial
Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial Open
The AS04-adjuvanted human papillomavirus (HPV)16/18 vaccine, an L1-based vaccine, provides strong vaccine efficacy (VE) against vaccine-targeted type infections, and partial cross-protection to phylogenetically-related types, which may be …
View article: Cohort profile: evaluation of immune response and household transmission of SARS-CoV-2 in Costa Rica: the RESPIRA study
Cohort profile: evaluation of immune response and household transmission of SARS-CoV-2 in Costa Rica: the RESPIRA study Open
Purpose The RESPIRA cohort aims to describe the nature, magnitude, time course and efficacy of the immune response to SARS-CoV-2 infection and vaccination, population prevalence, and household transmission of COVID-19. Participants From No…
View article: Age-Specific Prevalence of Anal and Cervical Human Papillomavirus Infection and High-Grade Lesions in 11 177 Women by Human Immunodeficiency Virus Status: A Collaborative Pooled Analysis of 26 Studies
Age-Specific Prevalence of Anal and Cervical Human Papillomavirus Infection and High-Grade Lesions in 11 177 Women by Human Immunodeficiency Virus Status: A Collaborative Pooled Analysis of 26 Studies Open
Background Age-specific data on anal, and corresponding cervical, human papillomavirus (HPV) infection are needed to inform female anal cancer prevention. Methods We centrally reanalyzed individual-level data from 26 studies reporting HPV …